Cell Biotech Co. Ltd. | Mutual Funds
Mutual Funds that own Cell Biotech Co. Ltd.
Government Pension Fund - Global (The)
401,417
4.26%
155,152
0%
12/31/2017
Fidelity Series Intrinsic Opportunities Fund
150,000
1.6%
0
0.04%
04/30/2018
OP Vaurastuva Keskiluokka
113,433
1.21%
55,165
1.55%
12/31/2017
Quoniam Fds. Selection SICAV - Emerg. Mkts. Equit. MinRisk
96,788
1.03%
96,788
0.13%
03/31/2018
iShares Core MSCI Emerging Markets ETF
93,531
1%
0
0.01%
09/05/2018
Vanguard Total International Stock Index Fund
74,107
0.79%
0
0%
07/31/2018
DFA Emerging Markets Core Equity Portfolio
68,287
0.73%
2,327
0.01%
04/30/2018
DFA Emerging Markets Small Cap Series
51,500
0.55%
0
0.02%
01/31/2018
37,672
0.4%
0
0.01%
07/31/2018
Vanguard Developed Markets Index Fund
31,477
0.34%
0
0%
07/31/2018
| Address |
50 Aegibong-ro 409beon-gil
Gimpo-si GY 10003
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.cellbiotech.com |
| Updated |
09/14/2018 |
| CELL BIOTECH Co., Ltd. engages in the manufacture and sale of probiotics products. Its products include probiotics, probiotic-related products, health functional food, general food, cleansing foam and bio-acitve cream for skin, and raw material probiotic products. The company was founded on February 7, 1995 and is headquartered in Gimpo-si, South Korea. |
